Cabaletta Bio Inc expected to post a loss of 44 cents a share - Earnings Preview

Cabaletta Bio

07/08/2023 19:34

* Cabaletta Bio Inc  CABA.OQ   CABA.O  is expected to show
no
change in quarterly revenue when it reports  results on August 9
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Cabaletta Bio Inc
is for
a loss of 44 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cabaletta
Bio Inc
is $15​, above​ its last closing price of $12.05. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.48       -0.48      -0.45     Beat    6.3
 Dec. 31 2023  -0.48       -0.45      -0.52     Missed  -15.1
 Sep. 30 2022  -0.47       -0.48      -0.39     Beat    19​
 Jun. 30 2022  -0.50       -0.50      -0.45     Beat    10.9
 ​​Mar.        -0.56       -0.60      -0.45     Beat    24.5
 31 2022                                                
 Dec. 31 2021  -0.64       -0.60      -0.49     Beat    19​
 Sep. 30 2021  -0.48       -0.50      -0.45     Beat    10.4
 Jun. 30 2021  -0.47       -0.50      -0.45     Beat    10.5
 This summary was machine generated August 7 at 18:33 GMT.  All
figures in US dollars  unless otherwise stated